rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Hermann Luebbert

CEO & Chairman

Company insider

Files Form 4 as: CEO & Chairman, Biofrontera.

In numbers

Trades disclosed
28
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
9 Dec 2021
Last trade
28 Jul 2026
Last filed
29 Jul 2026

Companies traded

Where they are an officer
BFRI BiofronteraDirector, Officer · Biotechnology · last 28 Jul 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
28 Jul 2026filed 29 Jul 2026BFRI BiofronteraBiotechnologySEC FORM 4 Code M—62,500filing
28 Jul 2026filed 29 Jul 2026BFRI Biofronteraoption or derivative · BiotechnologySEC FORM 4 Code M—62,500 at $0.00filing
28 Jul 2026filed 29 Jul 2026BFRI Biofronteraoption or derivative · BiotechnologySEC FORM 4 Code M—62,500 at $0.00filing
28 Jul 2026filed 29 Jul 2026BFRI BiofronteraBiotechnologySEC FORM 4 Code M—62,500filing
5 Mar 2026filed 6 Mar 2026BFRI BiofronteraBiotechnologySEC FORM 4 Code M—137,500filing
5 Mar 2026filed 6 Mar 2026BFRI Biofronteraoption or derivative · BiotechnologySEC FORM 4 Code M—137,500 at $0.00filing
5 Mar 2026filed 6 Mar 2026BFRI Biofronteraoption or derivative · BiotechnologySEC FORM 4 Code M—137,500 at $0.00filing
5 Mar 2026filed 6 Mar 2026BFRI BiofronteraBiotechnologySEC FORM 4 Code M—137,500filing
4 Mar 2026filed 6 Mar 2026BFRI Biofronteraoption or derivative · BiotechnologySEC FORM 4 Code A—125,000 at $0.00filing
4 Mar 2026filed 6 Mar 2026BFRI Biofronteraoption or derivative · BiotechnologySEC FORM 4 Code A—125,000 at $0.00filing
4 Mar 2026filed 6 Mar 2026BFRI Biofronteraoption or derivative · BiotechnologySEC FORM 4 Code A—125,000 at $0.00filing
4 Mar 2026filed 6 Mar 2026BFRI Biofronteraoption or derivative · BiotechnologySEC FORM 4 Code A—125,000 at $0.00filing
10 Sep 2025filed 16 Sep 2025BFRI Biofronteraoption or derivative · BiotechnologySEC FORM 4 Code M—137,500 at $0.00filing
10 Sep 2025filed 16 Sep 2025BFRI BiofronteraBiotechnologySEC FORM 4 Code M—137,500filing
22 Jul 2025filed 16 Sep 2025BFRI Biofronteraoption or derivative · BiotechnologySEC FORM 4 Code A—125,000 at $0.00filing
22 Jul 2025filed 16 Sep 2025BFRI Biofronteraoption or derivative · BiotechnologySEC FORM 4 Code A—125,000 at $0.00filing
12 Jul 2024filed 16 Jul 2024BFRI Biofronteraoption or derivative · BiotechnologySEC FORM 4 Code A—275,000 at $0.00filing
12 Jul 2024filed 16 Jul 2024BFRI Biofronteraoption or derivative · BiotechnologySEC FORM 4 Code A—275,000 at $0.00filing
18 May 2024filed 22 May 2024BFRI Biofronteraoption or derivative · BiotechnologySEC FORM 4 Code M—4,771 at $0.00filing
18 May 2024filed 22 May 2024BFRI BiofronteraBiotechnologySEC FORM 4 Code M—4,771filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Eugene Frederick LefflerChief Financial Officer · Chief Financial Officer at Biofrontera, filing Form 4 there in the last year
John J. Borer IIIDirector · Director at Biofrontera, filing Form 4 there in the last year
Beth J. HoffmanDirector · Director at Biofrontera, filing Form 4 there in the last year
Kevin Daniel WeberDirector · Director at Biofrontera, filing Form 4 there in the last year
Heikki LanckrietDirector · Director at Biofrontera, filing Form 4 there in the last year